Effects of stimulation site on diastolic function in cardiac resynchronization therapy.
BACKGROUND
Cardiac resynchronization therapy (CRT) improves left ventricular (LV) systolic function and clinical status, and prolongs survival of patients suffering from heart failure. An optimal LV site selection is key with respect to improvements in systolic function, though whether a site-specific effect on diastolic function exists is unclear. This study compared the effects of CRT on changes in systolic and diastolic function from 2 LV stimulation sites.


METHODS
We studied 21 patients in New York Heart Association functional classes >/= III, and a LV ejection fraction < 0.30 and QRS duration > 130 ms. CRT leads were placed in the right ventricle, right atrium, and coronary sinus tributaries. LV stimulation was applied from the postero-lateral and antero-lateral wall. A LV conductance catheter was used to measure LV systolic and diastolic function. Systolic responders had > 10% changes in dP/dt(max), and diastolic responders < 10% changes in tau during CRT versus baseline. Response was highly dependent on LV lead position for both diastolic and systolic function. Diastolic responders decreased from 29% to 10% of patients, and systolic responders from 76% to 48%, in the best versus the worst lead position, respectively. Improvements in diastolic function were less pronounced than in systolic function (relative change -14% vs +28%, P < 0.05). Overall, 45% were both systolic and diastolic responders, 17% were both systolic and diastolic nonresponders, and 38% had opposite responses.


CONCLUSIONS
Changes in systolic and diastolic function were both highly dependent on the LV stimulation site. Diastolic function was less influenced by CRT and a high proportion of patients had discordant results.
de Cock
Carel C
CC
Department of Cardiology, VU University Hospital, Amsterdam, The Netherlands. cc.dcock@vumc.nl
Vos
Dick H S
DH
Jessurun
Emile
E
Allaart
Cor P
CP
Visser
Cees A
CA
D002304:Cardiac Pacing, Artificial / Q000379:methods*; D003971:Diastole; D005260:Female; D006333:Heart Failure / Q000628:therapy*; D006339:Heart Rate; D006352:Heart Ventricles; D006801:Humans; D008297:Male; D010138:Pacemaker, Artificial; D013599:Systole; D016896:Treatment Outcome; D016277:Ventricular Function, Left